drug interactions with glp 1 Drug-Drug Interaction Studies Recommended for Novel GLP-1 Receptor Agonists Interaction between drugs and GLP-1
Description
95% CI 0.89, 0.96) and all-cause mortality rate (HR 0.70
A mechanistic guide to this next-generation metabolic peptide.
Certainly, the apparent advantage of tirzepatide, a dual incretin agonist, over GLP-1RA will spark renewed interest in the therapeutic potential of GIP in type 2 diabetes, obesity and related co-morbidities.
The reason
